Quarterly report pursuant to Section 13 or 15(d)

Investment in Joint Venture

v3.8.0.1
Investment in Joint Venture
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Note 3. Investment in Joint Venture

Pursuant to the Joint Venture Operating Agreement, both partners agreed that Enfission will serve as an exclusive vehicle to develop, license and sell nuclear fuel assemblies based on Company-designed metallic fuel technology and other advanced nuclear fuel intellectual property licensed to Enfission by the Company and Framatome or their affiliates. The joint venture builds on the joint fuel development and regulatory licensing work under previously signed agreements initiated in March 2016.

  

The Joint Venture Operating Agreement provided that the Company and Framatome each hold 50% of the total issued Class A voting membership units of the Joint Venture. The Company's investment accounted for under the equity method consist of the following as of March 31, 2018 (rounded in millions):

 

Investment Name  

Ownership

Interest

   

Carrying

Amount

 
Enfission, LLC     50 %     4.2  
Total - Equity Method Investment           $ 4.2  

 

The Company invested approximately $5.2 million in Enfission as of March 31, 2018. During the three-month period ended March 31, 2018, Enfission incurred a loss of approximately $1 million, and accordingly, the Company recorded its share of the loss in investment in Enfission, in accordance with the provisions in the joint venture operating agreement, of approximately $1.0 million in the accompanying condensed consolidated statement of operations. The Company’s investments exceeded the approximately $3.5 million that it was contractually bound to provide as of the inception of Enfission. The Company expects to continue providing additional equity contributions for the foreseeable future.

 

Summarized financial information for the Company’s equity method investee Enfission as of March 31, 2018 is presented in the following table (amounts in millions):

 

Current assets      
Cash   $ 5.4  
Other current assets     0.1  
Total assets   $ 5.5  
Current liabilities   $ 1.0  
Total liabilities   $ 1.0  

 

Summarized financial information for the Company’s equity method investee Enfission is presented in the following table for the period ended March 31, 2018 (amounts in millions):

 

Net sales and revenue   $ 0.0  
Research and development costs   $ 0.9  
Administrative expenses   $ 0.1  
Total Operating Loss   $ 1.0  
Loss from operations   $ 1.0  
Net loss   $ 1.0  

 

As of March 31, 2018, the total receivable due from Enfission was approximately $0.5 million which represents consulting fees charged to Enfission of approximately $0.4 million and reimbursed expenses paid by Lightbridge on Enfission’s behalf of $0.1 million.